Imagine an armband that, combined with special software, can tell you whether there is coagulation in the blood of a patient within 3-5 minutes of being worn? That technology may be here sooner than we think.
“The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic screening device that identifies certain biomarkers that are indicative of some types of conditions, such as hyper-coagulation (a condition causing blood to clot more easily than normal).”
Read more at:
Comentaris